Last reviewed · How we verify
Supra-therapeutic Dose
Supra-therapeutic Dose is a Small molecule drug developed by Chiesi Farmaceutici S.p.A.. It is currently in Phase 1 development.
At a glance
| Generic name | Supra-therapeutic Dose |
|---|---|
| Sponsor | Chiesi Farmaceutici S.p.A. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. (NA)
- The Effectiveness of Neurodevelopmental Treatment (Bobath) and Functional Physiotherapy in Children With Cerebral Palsy. (NA)
- Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50% (PHASE2)
- Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma (PHASE2)
- Effectiveness of Combined Super Inductive System (SIS) Therapy With Therapeutic Exercise and Health Education in Lateral Elbow Tendinopathy (NA)
- Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma (PHASE1)
- Robustness Evaluation of Deep Inspiration Breath-Hold (DIBH) Plans in Internal Mammary Irradiation
- Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Supra-therapeutic Dose CI brief — competitive landscape report
- Supra-therapeutic Dose updates RSS · CI watch RSS
- Chiesi Farmaceutici S.p.A. portfolio CI
Frequently asked questions about Supra-therapeutic Dose
What is Supra-therapeutic Dose?
Supra-therapeutic Dose is a Small molecule drug developed by Chiesi Farmaceutici S.p.A..
Who makes Supra-therapeutic Dose?
Supra-therapeutic Dose is developed by Chiesi Farmaceutici S.p.A. (see full Chiesi Farmaceutici S.p.A. pipeline at /company/chiesi-farmaceutici-s-p-a).
What development phase is Supra-therapeutic Dose in?
Supra-therapeutic Dose is in Phase 1.
Related
- Manufacturer: Chiesi Farmaceutici S.p.A. — full pipeline
- Compare: Supra-therapeutic Dose vs similar drugs
- Pricing: Supra-therapeutic Dose cost, discount & access